Wenchang Guo

647 total citations
21 papers, 491 citations indexed

About

Wenchang Guo is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Wenchang Guo has authored 21 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Epidemiology and 5 papers in Hepatology. Recurrent topics in Wenchang Guo's work include Heat shock proteins research (7 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Wenchang Guo is often cited by papers focused on Heat shock proteins research (7 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Wenchang Guo collaborates with scholars based in United States, China and Taiwan. Wenchang Guo's co-authors include David Ross, David Siegel, Philip Reigan, Joseph A. Zirrolli, Daniel L. Gustafson, Shaoyi Li, Yun Gao, Yunhui Liu, Gang Zhou and Kit S. Lam and has published in prestigious journals such as PLoS ONE, Cancer Research and Journal of Hepatology.

In The Last Decade

Wenchang Guo

19 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenchang Guo United States 11 347 69 56 54 50 21 491
Jingbo Yang China 15 310 0.9× 13 0.2× 56 1.0× 101 1.9× 80 1.6× 28 605
Reyaz ur Rasool India 17 370 1.1× 21 0.3× 64 1.1× 20 0.4× 97 1.9× 26 694
Chuanke Zhao China 14 364 1.0× 15 0.2× 47 0.8× 30 0.6× 114 2.3× 38 578
Dongjian Zhang China 14 187 0.5× 18 0.3× 15 0.3× 86 1.6× 26 0.5× 53 518
Małgorzata Kajstura United States 4 226 0.7× 16 0.2× 28 0.5× 21 0.4× 68 1.4× 7 379
Eiji Kumazawa Japan 16 388 1.1× 44 0.6× 23 0.4× 33 0.6× 35 0.7× 25 634
Yan‐yan Yan China 13 356 1.0× 26 0.4× 19 0.3× 56 1.0× 91 1.8× 14 655
Dinesh Raghu Australia 12 232 0.7× 54 0.8× 24 0.4× 31 0.6× 51 1.0× 20 459

Countries citing papers authored by Wenchang Guo

Since Specialization
Citations

This map shows the geographic impact of Wenchang Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenchang Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenchang Guo more than expected).

Fields of papers citing papers by Wenchang Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenchang Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenchang Guo. The network helps show where Wenchang Guo may publish in the future.

Co-authorship network of co-authors of Wenchang Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Wenchang Guo. A scholar is included among the top collaborators of Wenchang Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenchang Guo. Wenchang Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choi, Alyssa Y., Xiaodong Li, Wenchang Guo, et al.. (2023). Performance of Endoscopic Ultrasound-Guided Versus Percutaneous Liver Biopsy in Diagnosing Stage 3–4 Fibrosis. Digestive Diseases and Sciences. 68(9). 3774–3780. 2 indexed citations
2.
Choi, Alyssa Y., Kenneth J. Chang, Jason Samarasena, et al.. (2022). Endoscopic Ultrasound-Guided Porto-systemic Pressure Gradient Measurement Correlates with Histological Hepatic Fibrosis. Digestive Diseases and Sciences. 67(12). 5685–5692. 23 indexed citations
3.
Barbara, Mary, et al.. (2021). S2978 A Case of Severe Ischemic Duodenitis Secondary to Weight Loss Medication. The American Journal of Gastroenterology. 116(1). S1233–S1233.
4.
Guo, Wenchang, et al.. (2021). A limited panel of INSM1 and LEF1 immunostains accurately distinguishes between pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm. Pathology - Research and Practice. 223. 153462–153462. 5 indexed citations
5.
Guo, Wenchang, Whayoung Lee, Yunxia Lu, Xiaodong Li, & Vishal S. Chandan. (2020). Incidence and significance of GATA3 positivity in gallbladder adenocarcinoma. Human Pathology. 106. 39–44. 2 indexed citations
6.
Hashimoto, Rintaro, David P. Lee, Jason Samarasena, et al.. (2020). Comparison of Two Specialized Histology Needles for Endoscopic Ultrasound (EUS)-Guided Liver Biopsy: A Pilot Study. Digestive Diseases and Sciences. 66(5). 1700–1706. 19 indexed citations
7.
Lin, Tzu‐yin, Wenchang Guo, Qilai Long, et al.. (2016). HSP90 Inhibitor Encapsulated Photo-Theranostic Nanoparticles for Synergistic Combination Cancer Therapy. Theranostics. 6(9). 1324–1335. 70 indexed citations
9.
Lv, Yong, Xiangyi Meng, Wenchang Guo, et al.. (2016). Favorable Outcomes following Tips in Idiopathic Non-Cirrhotic Portal Hypertension with Variceal Bleeding: A Case-Control Study from a Single Center. Journal of Hepatology. 64(2). S659–S659. 1 indexed citations
10.
Li, Shaoyi, Wenchang Guo, Yun Gao, & Yunhui Liu. (2014). Ginsenoside Rh2 inhibits growth of glioblastoma multiforme through mTor. Tumor Biology. 36(4). 2607–2612. 21 indexed citations
11.
Li, Shaoyi, et al.. (2014). EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2. Tumor Biology. 35(6). 5593–5598. 55 indexed citations
12.
Gao, Yun, et al.. (2013). The Relationship Between Serum Lipoprotein (a) Levels and Ischemic Stroke Risk: A Cohort Study in the Chinese Population. Inflammation. 37(3). 686–693. 21 indexed citations
13.
Guo, Wenchang, Ruiwu Liu, Gaurav Bhardwaj, et al.. (2013). CTA095, a Novel Etk and Src Dual Inhibitor, Induces Apoptosis in Prostate Cancer Cells and Overcomes Resistance to Src Inhibitors. PLoS ONE. 8(8). e70910–e70910. 7 indexed citations
14.
Reigan, Philip, David Siegel, Wenchang Guo, & David Ross. (2011). A Mechanistic and Structural Analysis of the Inhibition of the 90-kDa Heat Shock Protein by the Benzoquinone and Hydroquinone Ansamycins. Molecular Pharmacology. 79(5). 823–832. 13 indexed citations
15.
Guo, Wenchang, Philip Reigan, David Siegel, & David Ross. (2008). Enzymatic Reduction and Glutathione Conjugation of Benzoquinone Ansamycin Heat Shock Protein 90 Inhibitors: Relevance for Toxicity and Mechanism of Action. Drug Metabolism and Disposition. 36(10). 2050–2057. 49 indexed citations
16.
Guo, Wenchang, David Siegel, & David Ross. (2008). Stability of the Hsp90 Inhibitor 17AAG Hydroquinone and Prevention of Metal‐Catalyzed Oxidation. Journal of Pharmaceutical Sciences. 97(12). 5147–5157. 12 indexed citations
17.
Reigan, Philip, Wenchang Guo, David Siegel, & David Ross. (2006). Molecular docking studies investigating the interaction of a series of benzoquinone ansamycin Hsp90 inhibitors with NAD(P)H:quinone oxidoreductase 1 (NQO1). Cancer Research. 66. 457–457. 1 indexed citations
18.
Guo, Wenchang, Philip Reigan, David Siegel, et al.. (2006). The Bioreduction of a Series of Benzoquinone Ansamycins by NAD(P)H:Quinone Oxidoreductase 1 to More Potent Heat Shock Protein 90 Inhibitors, the Hydroquinone Ansamycins. Molecular Pharmacology. 70(4). 1194–1203. 45 indexed citations
19.
Guo, Wenchang, Philip Reigan, David Siegel, et al.. (2005). Formation of 17-Allylamino-Demethoxygeldanamycin (17-AAG) Hydroquinone by NAD(P)H:Quinone Oxidoreductase 1: Role of 17-AAG Hydroquinone in Heat Shock Protein 90 Inhibition. Cancer Research. 65(21). 10006–10015. 127 indexed citations
20.
Teng, Michael Mu‐Huo, et al.. (1990). CT evaluation of polymorphic reticulosis. Neuroradiology. 31(6). 498–501. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026